Literature DB >> 22901872

Azithromycin in bronchiectasis: when should it be used?

Robert Wilson1, Athol U Wells.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22901872     DOI： 10.1016/S0140-6736(12)61261-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  The bronchiectasis severity index. An international derivation and validation study.

Authors:  James D Chalmers; Pieter Goeminne; Stefano Aliberti; Melissa J McDonnell; Sara Lonni; John Davidson; Lucy Poppelwell; Waleed Salih; Alberto Pesci; Lieven J Dupont; Thomas C Fardon; Anthony De Soyza; Adam T Hill
Journal:  Am J Respir Crit Care Med       Date:  2014-03-01       Impact factor: 30.528

2.  Poor survival in rheumatoid arthritis associated with bronchiectasis: a family-based cohort study.

Authors:  Xavier Puéchal; Emmanuelle Génin; Thierry Bienvenu; Claire Le Jeunne; Daniel J Dusser
Journal:  PLoS One       Date:  2014-10-13       Impact factor: 3.240

3.  Effect of Once-Weekly Azithromycin vs Placebo in Children With HIV-Associated Chronic Lung Disease: The BREATHE Randomized Clinical Trial.

Authors:  Rashida A Ferrand; Grace McHugh; Andrea M Rehman; Hilda Mujuru; Victoria Simms; Edith D Majonga; Mark P Nicol; Trond Flaegstad; Tore J Gutteberg; Carmen Gonzalez-Martinez; Elizabeth L Corbett; Sarah L Rowland-Jones; Katharina Kranzer; Helen A Weiss; Jon O Odland
Journal:  JAMA Netw Open       Date:  2020-12-01

4.  Bronchiectasis-associated hospitalizations in Germany, 2005-2011: a population-based study of disease burden and trends.

Authors:  Felix C Ringshausen; Andrés de Roux; Mathias W Pletz; Nina Hämäläinen; Tobias Welte; Jessica Rademacher
Journal:  PLoS One       Date:  2013-08-01       Impact factor: 3.240

Review 5.  The efficacy and safety of azithromycin in asthma: A systematic review.

Authors:  Bao-Ping Tian; Nanxia Xuan; Yesong Wang; Gensheng Zhang; Wei Cui
Journal:  J Cell Mol Med       Date:  2019-01-19       Impact factor: 5.310
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.